Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MRCP (UK)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Pulmonologist
MBBS, MRCP, FRACP, M.P.H., FACP (USA), FCCP (USA)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
Diabetologist
M.B.B.S., PGD Diabetes, MPhil Endocrine Physiology, Masters Family Medicine, Masters Family Medicine
Diabetologist
M.B.B.S., PGD Diabetes, MPhil Endocrine Physiology, Masters Family Medicine, Masters Family Medicine
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Internal Medicine Specialist
M.B.B.S, MRCP (UK)
Internal Medicine Specialist
MD
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures